Invention Grant
- Patent Title: Biguanide compositions and methods of treating metabolic disorders
- Patent Title (中): 双胍组合物和治疗代谢紊乱的方法
-
Application No.: US13547022Application Date: 2012-07-11
-
Publication No.: US08796338B2Publication Date: 2014-08-05
- Inventor: Alain D. Baron , Mark S. Fineman , Nigel R. A. Beeley
- Applicant: Alain D. Baron , Mark S. Fineman , Nigel R. A. Beeley
- Applicant Address: US CA San Diego
- Assignee: Elcelyx Therapeutics, Inc
- Current Assignee: Elcelyx Therapeutics, Inc
- Current Assignee Address: US CA San Diego
- Agency: Arnold & Porter LLP
- Agent Todd Lorenz
- Main IPC: A61K31/155
- IPC: A61K31/155 ; C07C279/26 ; A61K9/20 ; A61K9/00

Abstract:
Provided herein are methods for treating certain conditions, including diabetes, obesity, and other metabolic diseases, disorders or conditions by administrating a composition comprising a biguanide or related heterocyclic compound, e.g., metformin. Also provided herein are biguanide or related heterocyclic compound compositions, and methods for the preparation thereof for use in the methods of the present invention. Also provided herein are compositions comprising metformin and salts thereof and methods of use.
Public/Granted literature
- US20130095140A1 Biguanide Compositions and Methods of Treating Metabolic Disorders Public/Granted day:2013-04-18
Information query